Albumin-to-Fibrinogen Ratio as a Prognostic Biomarker in Acute Myeloid Leukemia

Authors

  • Ayman Fathy Abd El-halim , Heba Allah Elsayed Mohammed Abdelrhman , Ahmed Mahmoud Ali Ahmed , Elsayed Anany Metwally Mohamed Author

DOI:

https://doi.org/10.48047/evapgq14

Keywords:

Albumin-to-fibrinogen ratio; Acute myeloid leukemia; Prognostic biomarker

Abstract

Background: Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by clonal proliferation of myeloid precursor cells in the bone marrow and peripheral blood. Despite advances in molecular diagnostics and risk-adapted therapies, prognosis  remains poor for many patients, and accurate prognostic biomarkers are essential for improving risk stratification 

Downloads

Download data is not yet available.

References

Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136-1152.

Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations. Blood. 2017;129(4):424-447.

Downloads

Published

2024-11-20

Issue

Vol. 53 No. 03 (2024): Year 2024, Volume 53, Issue 3

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Albumin-to-Fibrinogen Ratio as a Prognostic Biomarker in Acute Myeloid Leukemia (Ayman Fathy Abd El-halim , Heba Allah Elsayed Mohammed Abdelrhman , Ahmed Mahmoud Ali Ahmed , Elsayed Anany Metwally Mohamed , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 7130-7139. https://doi.org/10.48047/evapgq14